A survey of studies analyzing effects of different vasopressors and their combinations indicated that application of AVP or V1aR agonist (selpressin) permits a reduction in the dose of norepinephrine, which is necessary for cardiovascular stabilization in patients with vasodilatory shocks resulting from sepsis, acute myocardial infarction or cardiovascular surgery [7,113]. Here, AVP is linked to myocardial infarction.